Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors
- PMID: 9105235
- DOI: 10.1097/00000542-199704000-00021
Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors
Abstract
Background: The N-methyl-D-aspartate (NMDA) subtype of glutamate receptor is blocked by ketamine, and this action likely contributes to ketamine's anesthetic and analgesic properties. Previous studies suggest that ketamine occludes the open channel by binding to a site located within the channel pore. This hypothesis was examined by investigating the effects of ketamine on single-channel currents from NMDA receptors.
Methods: The cell-attached and outside-out configurations of the patch clamp technique were used to study NMDA-activated currents recorded from cultured mouse hippocampal neurons.
Results: In cell-attached patches, NMDA evoked currents that had an apparent mean open time (tau o) of 3.26 ms. The probability of at least one channel being open (Po') was 0.058. The addition of ketamine (0.1 microM or 1 microM) to the pipette solution decreased Po' to 53% and 24% of control values, respectively. At 1 microM ketamine, this reduction was due to a decrease in both the frequency of channel opening and the mean open time (44% and 68% of control values, respectively). Ketamine did not influence channel conductance and no new components were required to fit the open- or closed-duration distributions. Ketamine (50 microM), applied outside the recording pipette, reduced the opening frequency of channels recorded in the cell attached configuration. This observation suggests that ketamine gained access to a binding site by diffusing across the hydrophobic cell membrane. In outside-out patches, ketamine potency was lower than that observed in cell-attached patches: 1 microM and 10 microM ketamine reduced Po' to 63% and 34% of control values, respectively, and this reduction was due primarily to a decrease in the frequency of channel opening with little change in mean open time.
Conclusions: These observations are consistent with a model whereby ketamine inhibits the NMDA receptor by two distinct mechanisms: (1) Ketamine blocks the open channel and thereby reduces channel mean open time, and (2) ketamine decreases the frequency of channel opening by an allosteric mechanism.
Similar articles
-
Single-channel properties of native and cloned rat vanilloid receptors.J Physiol. 2002 Nov 15;545(1):107-17. doi: 10.1113/jphysiol.2002.016352. J Physiol. 2002. PMID: 12433953 Free PMC article.
-
Sites of antagonist action on N-methyl-D-aspartic acid receptors studied using fluctuation analysis and a rapid perfusion technique.J Neurophysiol. 1988 Aug;60(2):645-63. doi: 10.1152/jn.1988.60.2.645. J Neurophysiol. 1988. PMID: 2902200
-
Ketamine Increases the Function of γ-Aminobutyric Acid Type A Receptors in Hippocampal and Cortical Neurons.Anesthesiology. 2017 Apr;126(4):666-677. doi: 10.1097/ALN.0000000000001483. Anesthesiology. 2017. PMID: 27984263
-
Pharmacodynamic elucidation of glutamate & dopamine in ketamine-induced anaesthesia.Chem Biol Interact. 2020 Aug 25;327:109164. doi: 10.1016/j.cbi.2020.109164. Epub 2020 Jun 7. Chem Biol Interact. 2020. PMID: 32524992 Review.
-
Ketamine a dissociative anesthetic: Neurobiology and biomolecular exploration in depression.Chem Biol Interact. 2020 Mar 1;319:109006. doi: 10.1016/j.cbi.2020.109006. Epub 2020 Feb 19. Chem Biol Interact. 2020. PMID: 32084352 Review.
Cited by
-
Ketamine-induced neuronal damage and altered N-methyl-D-aspartate receptor function in rat primary forebrain culture.Toxicol Sci. 2013 Feb;131(2):548-57. doi: 10.1093/toxsci/kfs296. Epub 2012 Oct 11. Toxicol Sci. 2013. PMID: 23065140 Free PMC article.
-
Allosteric inhibition of NMDA receptors by low dose ketamine.Mol Psychiatry. 2024 Sep 5. doi: 10.1038/s41380-024-02729-9. Online ahead of print. Mol Psychiatry. 2024. PMID: 39237721
-
The Role of GluN2C-Containing NMDA Receptors in Ketamine's Psychotogenic Action and in Schizophrenia Models.J Neurosci. 2016 Nov 2;36(44):11151-11157. doi: 10.1523/JNEUROSCI.1203-16.2016. J Neurosci. 2016. PMID: 27807157 Free PMC article.
-
Differential binding properties of [3H]dextrorphan and [3H]MK-801 in heterologously expressed NMDA receptors.Neuropharmacology. 2005 Jul;49(1):1-16. doi: 10.1016/j.neuropharm.2005.01.029. Epub 2005 Apr 1. Neuropharmacology. 2005. PMID: 15992576 Free PMC article.
-
The place of S-ketamine in fibromyalgia treatment (ESKEFIB): study protocol for a prospective, single-center, double-blind, randomized, parallel-group, dose-escalation controlled trial.Trials. 2021 Nov 27;22(1):853. doi: 10.1186/s13063-021-05814-4. Trials. 2021. PMID: 34838114 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources